a public good project by the
Synthesis
Company
of California

© 2026

In vitro characterization of commercial factor VIII concentrates: Long-term follow-up | doi.page

0 citations0 references

Google Scholar doi.org

In vitro characterization of commercial factor VIII concentrates: Long-term follow-up

Annals of Hematology·1984·Vol. 49(1), pp. 53–59

Citations Over Time

C. Miyashita, Peter Hellstern, M. K�hler, Gerhard von Blohn, E. Wenzel

Related Papers

→ Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin(2006)35 cited
Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.(1984)
→ Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans(1984)20 cited
→ The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type(1988)5 cited
→ Comparative Performance of Three Anti-Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin(2006)1 cited